Why is Sanofi India Ltd ?
1
High Management Efficiency with a high ROE of 43.30%
2
The company is Net-Debt Free
3
Poor long term growth as Net Sales has grown by an annual rate of -9.00% and Operating profit at -7.95% over the last 5 years
4
Flat results in Mar 26
- NO KEY NEGATIVE TRIGGERS
5
With ROE of 48.7, it has a Very Attractive valuation with a 11.5 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -44.44%, its profits have fallen by -12.8%
- At the current price, the company has a high dividend yield of 3.6
6
High Institutional Holdings at 26.77%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -44.44% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Sanofi India should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sanofi India for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sanofi India
-44.52%
-2.29
19.46%
Sensex
-6.04%
-0.47
13.30%
Quality key factors
Factor
Value
Sales Growth (5y)
-9.00%
EBIT Growth (5y)
-7.95%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
2.17
Tax Ratio
25.76%
Dividend Payout Ratio
86.59%
Pledged Shares
0
Institutional Holding
26.77%
ROCE (avg)
116.06%
ROE (avg)
43.30%
Valuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
35
Price to Book Value
11.50
EV to EBIT
17.66
EV to EBITDA
16.26
EV to Capital Employed
18.68
EV to Sales
4.24
PEG Ratio
NA
Dividend Yield
3.64%
ROCE (Latest)
116.18%
ROE (Latest)
48.73%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Bearish






